Physician profile
Bertrand Roche
NPI 1639134174
$4,172.66
in general payments reported to CMS, 2019-2025
31 companies · $591 in 2025
The $591 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $896 · 2020: $216 · 2021: $148 · 2022: $723 · 2023: $861 · 2024: $737 · 2025: $591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,189.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $631.58 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $423.21 | 2019-2025 | Spiriva Respimat, Stiolto Respimat, Jardiance |
| Abbvie INC. | $337.14 | 2019-2025 | Vraylar |
| Exact Sciences Corporation | $305.67 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novo Nordisk INC | $305.05 | 2019-2025 | Ozempic, Rybelsus |
| Pfizer INC. | $233.49 | 2019-2025 | |
| Glaxosmithkline, LLC. | $200.88 | 2019-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Kowa Pharmaceuticals America, INC. | $176.48 | 2019-2022 | |
| Amgen INC. | $164.13 | 2019-2025 | Otezla, Repatha, Otezla |
| Astrazeneca Pharmaceuticals LP | $160.84 | 2019-2024 | Breztri, Farxiga |
| Amarin Pharma, INC. | $154.03 | 2019-2023 | |
| Penumbra, INC. | $148.00 | 2021 | |
| Phathom Pharmaceuticals, INC. | $112.08 | 2023-2025 | Voquezna |
| Janssen Pharmaceuticals, INC | $108.42 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $103.37 | 2019-2025 | Capvaxive, Gardasil 9, Gardasil |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $93.36 | 2023-2025 | Sapien 3 Ultra Resilia |
| E.R. Squibb & Sons, L.L.C. | $88.85 | 2019-2023 | Eliquis |
| Bayer Healthcare Pharmaceuticals INC. | $68.76 | 2022 | |
| Abbott Laboratories | $56.27 | 2019-2023 | Freestyle Libre 3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $47.71 | 2025 | Xifaxan |
| Seqirus USA INC | $37.10 | 2025 | Flucelvax, Fluad |
| Ars Pharmaceuticals Operations, INC. | $37.09 | 2025 | Neffy |
| Daiichi Sankyo INC. | $35.29 | 2019-2020 | |
| Vbi Vaccine (Delaware) INC. | $29.00 | 2023 | Prehevbrio |
| Biohaven Pharmaceutical Holding Company LTD. | $21.69 | 2022 | |
| Allergan, INC. | $20.14 | 2020 | |
| Paratek Pharmaceuticals, INC. | $18.34 | 2022 | |
| Boston Scientific Corporation | $15.49 | 2019 | |
| Grifols USA, LLC | $14.09 | 2019 | |
| Dexcom, INC. | $12.88 | 2023 | Dexcom G6 Transmitter |
| Takeda Pharmaceuticals U.S.A., INC. | $12.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bertrand Roche listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.